Jane Grogan, Ph.D., took over Biogen’s research department in the wake of large-scale layoffs. Now, a little more than a year later, she’s making cuts of her own.
The neuro-focused biotech is “making changes” to its research team to “reinvigorate the company's drug discovery capabilities and support long-term sustainable growth,” a Biogen spokesperson told Fierce Biotech via email.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,